Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$25.80
+2.52%
Mkt Cap $1.18B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (16 analysts)
$47.75
Range $13.00 – $62.00
Implied Upside
+85.1%
Consensus $47.75 vs current $25.80
NASDAQ·Healthcare·Biotechnology
$25.80
+2.52%
Mkt Cap $1.18B
Buy
6
Hold
0
Sell
0
Price Target (16 analysts)
$47.75
Range $13.00 – $62.00
+85.1%
Consensus $47.75 vs current $25.80